Prof. Dr. Deniz Tasdemir is a Full Professor (W3) of Marine Natural Products Chemistry at GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel and serves as Director of the GEOMAR-Biotech center and Head of the Marine Natural Product Chemistry Research Unit. Her career spans institutions including the National University of Ireland Galway and UCL School of Pharmacy. PhD in Pharmacy, ETH Zurich (1997) Post-doctoral work, University of Utah (2001) Dr. Helmut Legerlotz Fellowship, University of Zurich (2002-2025) Her research focuses on marine chemical ecology , metabolomics , and bioprospecting for bioactive compounds from sponges, algae, and marine microbiomes. Recent work explores seagrass pathogen reduction, microbiome interactions, and aquafeed applications. Scientific awards include: Waters Award for Natural Products Innovation (2016) Egon Stahl Silver Medal (2005) Pierre Fabre Prize (2004) ETH Zurich Medal (1997) She leads collaborative projects on ocean sustainability and marine drug discovery, with editorial roles in Marine Drugs , Planta Medica , and Phytochemistry Letters .
Caroline Lemieux is an Assistant Professor at the Department of Computer Science, University of British Columbia (UBC), with research focused on advancing software correctness, security, and performance through innovative testing and synthesis techniques. Her work bridges Programming Languages and Software Engineering , particularly in fuzz testing, specification mining, and program synthesis. PhD from University of California, Berkeley (2021), advised by Koushik Sen Postdoctoral researcher at Microsoft Research, NYC (2021-2022) Key contributions: FuzzFactory , CodaMOSA , Arvada , and Gauss Her research integrates machine learning with traditional testing methods, exemplified by projects like RLCheck (reinforcement learning for test generation) and AutoPandas (neural synthesis for dataframes). Recent publications analyze generator-based fuzzing challenges and propose hybrid strategies combining coverage feedback with AI-driven insights. Scientific Awards : ACM/SIGSOFT Best Paper Award (ESEC/FSE 2019) ACM/SIGSOFT Tool Demonstration Award (ISSTA 2019) ACM/SIGSOFT Distinguished Artifact Award (ISSTA 2019) NSERC Postgraduate Scholarship-Doctoral (PGS D) UBC Governor General's Silver Medal (2016) Teaching roles include: 2025W2: CPSC 539L - Topics in Programming Languages 2024W2: CPSC 410 - Advanced Software Engineering 2023W2: CPSC 410 (with Alex Summers) She supervises graduate and undergraduate researchers working on projects like ExploTest (automated unit test generation) and GRIMOIRE (grammar extraction from pseudo-rules). Her research team collaborates with institutions including Microsoft Research, Google, and academic partners in systems security and AI-driven testing.
Prof. Raffaele Mezzenga is a Full Professor at ETH Zürich's Department of Health Sciences and Technology and Head of the Institute of Food, Nutrition, and Health. He earned his master's from Perugia University (Italy) and a PhD in Polymer Physics from EPFL, followed by postdoctoral work at UC Santa Barbara. His career includes roles at the Nestlé Research Center and the University of Fribourg before joining ETH in 2009. His research focuses on self-assembly processes in polymers, biopolymers, and colloidal systems, with applications in environmental remediation, bioplastics, and biomedical materials. Key contributions include pioneering protein-based materials and advancing understanding of amyloid fibrils. Education: Master's, Materials Science & Engineering, Perugia University PhD, Polymer Physics, EPFL Research Interests: Self-assembly, biopolymers, amyloid materials, sustainable technologies, food colloids, and soft condensed matter. Awards: 2011 AOCS Award, 2017 APS Fellowship, and 2013 Biomacromolecules Young Investigator Award. Visiting Roles: Held visiting professorships at Aalto University, RMIT, Monash University, Nanyang Technological University, and others. Labs/Teams: Leads the Institute of Food, Nutrition, and Health at ETH, focusing on interdisciplinary research in food science and biomaterials. His work bridges fundamental science and applied innovation, addressing global challenges in sustainability and health through materials science. Recent projects include creating bioplastics from food waste, developing amyloid-based water purification systems, and advancing targeted drug delivery via lipidic mesophases.
Qing Li is an Associate Professor in the Department of Electrical and Computer Engineering at Carnegie Mellon University (CMU), part of the College of Engineering. He holds a B.E. in Electronics Engineering from Tsinghua University (2006) and a Ph.D. in Electrical and Computer Engineering from Georgia Institute of Technology (2013). Prior to CMU, he worked as a postdoctoral researcher at the National Institute of Standards and Technology (NIST), where he developed quantum frequency conversion and microresonator-based optical systems. His research focuses on light-matter interactions in integrated photonics, emphasizing nonlinear optics and quantum information processing. He has pioneered silicon carbide and aluminum nitride platforms for chip-scale quantum technologies and optical metrology. Dr. Li has been recognized with prestigious awards including the Darpa Young Faculty Award (2019), OSA Paul F. Forman Team Engineering Excellence Award (2020), and Sigma Xi Best Ph.D. Thesis Award (Georgia Tech). His work bridges classical and quantum information systems, with applications in secure communication, atomic systems interrogation, and high-precision frequency synthesis. He actively contributes to the Pittsburgh Quantum Institute (PQI), advancing regional quantum engineering initiatives. His research group’s key projects include developing compact optical frequency synthesizers, soliton microcombs for communication grids, and entangled photon pair sources for quantum networks. Grants and collaborations support his exploration of novel photonic materials and devices, targeting advancements in both fundamental science and applied technologies.
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Metin Sitti is a Professor and currently serves as a part-time adjunct professor at Koç University's Faculty of Medicine and Engineering. He is also the President of Koç University and Director of the Max Planck Institute for Intelligent Systems since 2014. His research spans robotics , micro/nanorobotics , physical intelligence , bio-inspired robotics , and materials science . Undergraduate: Boğaziçi University (Electrical and Electronics Engineering, 1992) Master's: Boğaziçi University (1994) PhD: University of Tokyo (Electrical Engineering, 1999) His research focuses on small-scale robotics for biomedical applications, including magnetic microrobot swarms , biohybrid systems , and functional materials . Recent publications emphasize 3D control , wireless actuation , and clinical translation of robotic systems. Scientific Awards : 2020 Scientific Breakthrough of the Year 2018 Koç University Rahmi M. Koç Science Medal 2014 IEEE/ASME Best Mechatronics Paper Award 2013/2012 World RoboCup Micro-Robotics First Prize He has advised numerous students and collaborates with institutions like Carnegie Mellon University and University of Stuttgart. His work integrates physical intelligence into miniature robots for medical imaging , drug delivery , and autonomous systems .
Christian Friedrich Wilhelm Becker is a full Professor at the University of Vienna, holding a position within the Faculty of Chemistry and the Department of Biological Chemistry. His research profile shows extensive activity in protein chemistry and biochemistry, with particular focus on post-translational modifications and their implications in disease mechanisms. His work bridges chemical biology, biochemistry, and biomedical applications, contributing significantly to the academic and research landscape at one of Europe's oldest and most prestigious universities. Faculty of Chemistry, University of Vienna Department of Biological Chemistry Active research leader with numerous ongoing projects Significant publication record spanning multiple disciplines Professor Becker's research primarily focuses on protein chemistry, particularly post-translational modifications and their role in protein function and dysfunction. His work spans multiple interconnected areas including ubiquitination, protein aggregation, prion protein behavior, and biomimetic approaches to protein analysis. His research has significant implications for understanding neurodegenerative diseases and developing novel therapeutic approaches. The fingerprint analysis of his work shows strong connections to biochemistry, molecular biology, and chemistry, with particular emphasis on cysteine chemistry, glycosylation, and amino acid modifications. Analysis of Professor Becker's recent publications (2021-2025) reveals a consistent research trajectory focused on protein modification techniques and their biological implications. His work shows increasing sophistication in chemical biology approaches to study protein function, with particular emphasis on ubiquitination pathways and protein aggregation mechanisms. The integration of chemical synthesis methods with biological analysis represents a hallmark of his research approach. His publications span high-impact journals in biochemistry, chemical biology, and peptide science, demonstrating the interdisciplinary nature of his contributions. Professor Becker has received notable recognition for his research contributions, most prominently the Cathay Award in 2020. This award acknowledges his significant contributions to the field of protein chemistry and chemical biology. His work appears to have practical applications in therapeutic development, particularly in the areas of targeted protein degradation and immunotherapy, which likely contributed to this recognition. Cathay Award (2020) Professor Becker leads multiple significant research projects, including 'Targeted protein degradation - from small molecules to complex organelles' (2020-2024), 'Taktira: Development of an improved, low-side-effect and sustainable immunotherapy' (2019-2023), and 'Structure Zoom: Zooming in on protein functional sites with atomic resolution' (2018-2021). These projects demonstrate substantial grant funding and collaborative research efforts across multiple institutions. His active participation in 290 recorded activities through 2025 indicates a highly engaged research program with numerous collaborators and trainees. Targeted protein degradation project (2020-2024) Taktira immunotherapy project (2019-2023) Structure Zoom project (2018-2021) Professor Becker's research environment includes a robust team of collaborators and junior researchers, as evidenced by the numerous co-authored publications and activities. His work intersects with multiple research groups studying protein function, modification, and therapeutic applications. The international collaboration network shown in his profile indicates significant engagement with researchers across multiple countries, creating a dynamic research ecosystem focused on advancing protein science and its biomedical applications.
Mats Danielsson is a Professor at KTH Royal Institute of Technology, leading the Medical Imaging research group within the Department of Particle Astrophysics and Medical Imaging. He has coordinated major projects like the ERC Advanced Grant for the Si3 project (starting 2024) and the EIC Pathfinder's 1MICRON project (starting 2025). His work focuses on advancing photon-counting detectors, X-ray technologies, and medical imaging systems. Notable recognitions include the 2024 KTH Innovation Award and the 2022 Hans Wigzell Science Prize. Danielsson has co-founded companies such as Sectra Mamea AB and C-RAD AB, and holds 135 patents with over 150 scientific publications. Education: MSc (1990) and PhD (1996) from KTH, followed by postdoctoral research at Lawrence Berkeley National Lab (1996–1998). He joined KTH in 1999, where he has held his current professorship since then. His research spans medical imaging, detector innovation, and radiation physics applications in healthcare. Research Interests: Development of high-resolution CT detectors, photon-counting technologies, compact X-ray sources, and AI-driven image processing. His recent work emphasizes minimizing radiation exposure while enhancing diagnostic precision through novel detector designs and machine learning algorithms. Key Projects: ERC Si3 project (3D detector for nuclear medicine), EIC 1MICRON (micrometer-scale imaging), and MedTechLabs collaboration with Karolinska Institutet. He has pioneered innovations such as MicroDose mammography and advanced photon-counting spectral CT systems. Awards: KTH Innovation Award (2024), Hans Wigzell Prize (2022), IVA membership (2017), Polhem finalist (2014), and INGVAR Award (2004). Advising & Grants: Over 150 scientific publications, 135 patents, and leadership in multi-institutional projects. Teaches courses on medical imaging and modern physics at KTH. Labs/Teams: Director of the Medical Imaging Group at KTH, co-founder of MedTechLabs, and collaborator across academia and industry in medical imaging innovation.
Andrew S. Rosen is an Assistant Professor in the Department of Chemical and Biological Engineering at Princeton University, leading the Rosen Research Group since his appointment. He became an associated faculty member of the Princeton Plasma Physics Laboratory (PPPL) in June 2025, expanding his collaborative impact in energy research. His work focuses on computationally guided materials discovery to address urgent sustainability challenges beyond traditional trial-and-error approaches. Education Ph.D. in Chemical Engineering, Northwestern University (2021) B.S. in Chemical Engineering, Tufts University (2015) Research Focus Dr. Rosen integrates quantum-chemical calculations , high-throughput computing , and machine learning to design novel materials for energy storage, catalysis, and environmental applications. His group specializes in porous framework solids and molecular materials with tailored electronic properties, emphasizing synthesis pathways to bridge computational predictions with experimental realization. This research targets unprecedented materials for clean energy technologies through AI-enhanced quantum modeling. Research Support NSF grant awarded June 25, 2025 ScienceAtScale NERSC Award received June 10, 2025 Invited speaker at ASE CECAM Workshop (June 24, 2025) Group and Collaborations The Rosen Research Group leverages open-source software and big data initiatives like the Materials Project, maintaining strong ties with experimental teams to validate computational discoveries. Their work directly addresses climate challenges through materials innovation, with recent focus on electronic structure properties for catalytic applications.
Pim de Vink is a doctoral researcher at Eindhoven University of Technology , affiliated with the Biomedical Engineering department and Chemical Biology group. Supervised by dr. L.-G. Milroy and prof. L. Brunsveld , his work bridges supramolecular chemistry and chemical biology , focusing on host/guest chemistry for protein complex modulation. Education: B.Sc. in Chemistry (2014) from University of Amsterdam M.Sc. in Biomedical Engineering (2016) from TU/e Internship at Max Planck Institute for Molecular Physiology (2016) on gold-catalyzed synthesis Research Themes: His research develops switchable cucurbituril-based systems for light-controlled enzyme activation and artificial signaling networks. Key areas include protein-protein interaction stabilization , thermodynamic modeling , and allosteric nuclear receptor modulation . Publication Trends: Across JACS , Chemical Science , and RSC Chemical Biology , his work from 2017–2023 emphasizes supramolecular tools for biochemical applications. Notable contributions include 100-fold affinity enhancement of 14-3-3 ligands and UV-responsive cucurbituril release mechanisms . Grants: Funded by Netherlands Organization for Scientific Research (NWO) through Gravity program 024.001.035 and VICI grant 016.150.366.
Amy E. Fraley is an Assistant Professor at ETH Zürich, Department of Chemistry and Applied Biosciences, and leads the Medicinal Chemistry Research Group. Her cross-disciplinary work bridges natural products biosynthesis, pharmaceutical sciences, and environmental sustainability through enzymatic chemistry and biotechnology. BSc in Chemistry, Millersville University of Pennsylvania (2014) PhD in Medicinal Chemistry, University of Michigan College of Pharmacy (2019) Postdoctoral work at ETH Zürich Institute of Microbiology under Prof. Jörn Piel Her research focuses on harnessing biosynthetic enzymes (e.g., halogenases, monooxygenases, Diels-Alderases) to create sustainable bioactive metabolites. She explores natural product biosynthesis in fungi and marine bacteria, targeting disease mechanisms and green chemistry applications. Recent work includes metagenomic studies of Lake Chilika microbial mats and polyketide synthase engineering. Notable scientific awards include the 2024 JSP Fellow at Bürgenstock Conference, 2018 Rackham Predoctoral Fellowship, and multiple University of Michigan honors. Her group secured funding from the ETH4D Doctoral Mentorship Grant and Messerli Foundation . Collaborations span structural biology, synthetic chemistry, and microbiology, with key contributions to flavoenzyme characterization and bioactive compound libraries . The lab emphasizes interdisciplinary training and innovation in biocatalytic tools for organic synthesis.
Professor Athanassios Manikas holds the Chair of Communications & Array Processing in the Department of Electrical & Electronic Engineering at Imperial College London, part of the Faculty of Engineering. He is a Fellow of both the IET and IMA, and has held significant editorial roles including Associate Editor for IEEE Transactions on Aerospace and Electronic Systems. His research focuses on wireless communications, radar systems, antenna array processing, and applied mathematics, with over 50 supervised PhD students and 150+ Masters projects. He leads Imperial's research group in array processing and has extensive industry collaborations, including technical leadership of the University Defence Technology Centre in Signal Processing (2008-2013). Awards include the IEEE PIMRC 2022 Best Paper Award and recognition as an IEEE COMSOC Distinguished Lecturer (2016-2017). His work integrates differential geometry principles with array processing, as detailed in his monograph Differential Geometry in Array Processing . Professor Manikas has served as an expert witness in high-profile cases and contributes to academic governance roles such as the Royal Society's International Fellowship Committee. His research group is affiliated with the Space Lab at Imperial, focusing on innovative applications of array signal processing in aerospace and defense systems.
Joel Weadge is an Associate Professor in the Biology Department at Wilfrid Laurier University , Waterloo, Ontario. His research focuses on bacterial biofilms, glycobiology, and protein structure-function relationships. Contact: jweadge@wlu.ca , Office: BA425 (Bricker Academic). Education: PhD in Microbiology (University of Guelph, 2006) BSc (Hons) in Microbiology (University of Guelph, 2000) Research Interests center on bacterial biofilms as virulence factors in pathogens like E. coli and Salmonella . Key areas include: Structural and functional characterization of biofilm proteins (cellulose, curli fimbriae) Enzymology of carbohydrate modifications (acetylation, phosphoethanolamine transfer) Developing therapeutics targeting biofilm synthesis Biopolymer applications for medical/industrial use Publications highlight studies on Pseudomonas and Salmonella biofilm mechanisms, glycosyltransferases, and carbohydrate-active enzymes, with methodologies spanning X-ray crystallography to high-throughput biofilm profiling. Labs and Teams: The Weadge Lab investigates biofilm roles in food/water security and oral health, utilizing enzymology, mass spectrometry, and structural biology. Current members include graduate students, technicians, and research assistants.
C. Perry Chou is a full professor in the Chemical Engineering Department at the University of Waterloo, with a cross-appointment in Biology. He holds a BSc and MSc from National Taiwan University and a PhD from Rice University, all in Chemical Engineering. His research focuses on integrating biochemical, genetic, and metabolic engineering strategies to enhance biomanufacturing using microbial cell factories. Key areas include recombinant protein production, microbial biotechnology, and biofuel development. Education: PhD in Chemical Engineering, Rice University (1995) MSc in Chemical Engineering, National Taiwan University (1987) BSc in Chemical Engineering, National Taiwan University (1984) Research Interests: Dr. Chou’s work spans biochemical engineering, bioprocessing, and metabolic engineering. He develops strategies for microbial strain construction, fermentation optimization, and bioproduct purification. His research bridges fundamental biological sciences with applied engineering to advance biomanufacturing. Publications: His 90+ peer-reviewed articles highlight contributions to strain engineering, CRISPR-Cas9 tools, and microbial production of chemicals like 5-aminolevulinic acid and propionate. Recent trends emphasize nanomaterial applications (e.g., graphene oxide) and sustainable biofuel pathways. Awards: Canada Research Chair (Canada) 1000-talent Award (China) Advising & Grants: Dr. Chou actively mentors graduate students and contributes to editorial roles at journals like Biotechnology Advances and Scientific Reports . He teaches courses such as CHE 161 (Engineering Biology) and CHE 562 (Advanced Bioprocess Engineering). Labs/Teams: Collaborates with interdisciplinary teams to advance bioprocess development, though specific lab names are not explicitly mentioned in the text.
Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models